Browsing Tag
Sean McClain
6 posts
Could one hair loss antibody make Absci’s AI drug platform harder to ignore?
Absci’s ABS-201 data and $100 million raise sharpen ABSI’s AI biologics story across androgenetic alopecia, endometriosis and platform validation.
Absci goes full throttle on AI drug design with Oracle and AMD in its corner
Absci taps Oracle Cloud and AMD’s Instinct GPUs to fast-track AI-powered drug discovery and antibody design. Find out what this means for biotech’s future.
Absci and AMD collaborate to transform AI-driven drug discovery
Absci Corporation and Advanced Micro Devices, Inc. (AMD) have unveiled a strategic collaboration designed to revolutionise drug discovery…
Absci, PrecisionLife collaborate to develop novel biotherapeutics for chronic diseases
Absci (Nasdaq: ABSI), a generative AI drug creation company, and PrecisionLife, a leader in computational biology, today announced…
Absci collaborates with AstraZeneca for AI-designed oncology antibody
Absci Corporation (Nasdaq: ABSI), a leader in generative AI antibody discovery, announced a groundbreaking collaboration with AstraZeneca, a…
Montauk Renewables announces landfill gas-to-energy project in Irvine, CA
Montauk Renewables, via its subsidiary Bowerman Power LFG, has unveiled plans for the development of a renewable natural…